Crossmark

Mycobacterium tuberculosis bacteriology and immunity necessitate a multi-pronged immune strategy for vaccination

Published Online: 2026-04-04

Authors

Poolman, Jan T.
Funding

Funding for this research was provided by:

Novo Nordisk Foundation Initiative on Vaccines and Immunity (NIVI) that is supported by the Novo Nordisk Foundation (NNF23SA0088562)
License Information

Text and Data Mining valid from 2026-04-04

Accepted Manuscript valid from 2026-04-04
More Information

Article History

Received: 8 October 2025

Accepted: 22 January 2026

First Online: 4 April 2026

Competing interests

: The author declares no competing interests.

Document is current